DeZwarteRidder schreef op 3 februari 2014 16:45:
[...]
PHARMING HEEFT ROTH BETAALD VOOR DIT RAPPORT:
---------------------------------------------
Disclosures:
Within the last twelve months, ROTH has received compensation for investment banking services from Pharming Group
NV (OTC: PHGUF).
ROTH makes a market in shares of Salix Pharmaceuticals, Ltd. and Santarus, Inc. and as such, buys and sells from
customers on a principal basis.
Shares of Pharming Group NV (OTC: PHGUF) may be subject to the Securities and Exchange Commission's Penny Stock
Rules, which may set forth sales practice requirements for certain low-priced securities.
Shares of Pharming Group NV (OTC: PHGUF) may not be eligible for sale in one or more states.
A Research Analyst and/or a member of the Analyst's household own(s) shares of Santarus, Inc. stock.
On September 28, 2010, ROTH changed its rating system in order to replace the Hold rating with Neutral.
On May 26, 2011, ROTH changed its rating system in order to incorporate coverage that is Under Review